A noval vaccine formulation consisting of DNA vaccine inactivated virus

Rangarajan, Pundi Narasimhan and Srinivasan, Villuppanoor Alwar and Biswas, Subhabrata and Reddy, Guddeti Sreenivasa (2002) A noval vaccine formulation consisting of DNA vaccine inactivated virus. Patent Number(s) WO 02078732 A1. Patent Assignee(s) Indian Institute of Science;Indian Immunologicals Limited.

Preview

PDF patent1.pdf Download (1MB)

Abstract

Disclosed herein is a novel vaccine formulation for prophylactic or therapeutic immunization of vertebrates against infections caused by vertebrate viruses. The said vaccine contains a min. of two components, one of which is a deoxyribonucleotide (DNA) vaccine comprising of a DNA mol. that encodes a polypeptide of the virus and the other component consisting of inactivated form of the virus. This invention can also be used to develop low cost inactivated virus-based vaccines that contain much lower amt. of the said virus than that present in similar vaccines known in the prior art. The examples focus on the methods of producing a novel vaccine compn. against the rabies virus.

Item Type:	Patent
Department/Centre:	Division of Biological Sciences > Biochemistry
Date Deposited:	06 Apr 2005
Last Modified:	19 Sep 2010 04:18
URI:	http://eprints.iisc.ac.in/id/eprint/3039

Actions (login required)

View Item